Nulla Bio's Cas12a-targeted insertion platform enables precise 7–10 kb DNA integration in tomato, soybean, and oilseed rape. It combines geminiviral replicon donor amplification, NHEJ-suppression via KUDN tethering, SunTag-assembled donor recruitment, and a chemical-inducible timing layer to overcome bottlenecks in large-fragment insertion in dicot crops.
Nulla Bio offers a Cas12a-guided targeted-insertion platform designed to overcome the three linked bottlenecks that limit large-fragment DNA integration in dicot crops: insufficient donor availability, low productive donor use at the break site, and competing non-homologous end joining (NHEJ). The platform delivers precise, homology-directed repair (HDR)-resolved insertion of 7–10 kb payloads at predefined genomic loci, with a roadmap toward larger cargos and multi-locus stacking. It uses LbCas12a exclusively and operates within standard 25–30 °C regeneration windows, avoiding heat-shock steps. Phase 1 is anchored in tomato, with soybean and oilseed rape following in subsequent phases.
Core technology layers:
Benchmarking and optimization variables:
Intellectual property: Three patent families (KR/US/CN/CA) protect the core platform components.
The platform builds on individually validated backbone layers from prior peer-reviewed work in tomato. Phase 1 (Year 1) benchmarks the three configurations in tomato against a defined go/no-go criterion of 2.5% precise single-copy insertion of a 7–10 kb payload. Achievement of this milestone triggers Phase 2 (Year 2), extending the platform to soybean with adapted induction dosing for cotyledonary-node explants and to oilseed rape via the R2S-T regeneration route validated in Brassica oleracea. A conditional Phase 3 addresses scaling toward 25 kb payloads and multi-locus stacking in allotetraploid Brassica napus. The technology is currently at a validated-component stage, with integrated platform performance being actively demonstrated.
Nulla Bio Inc. is a genome editing company specializing in crop innovation to address challenges in agriculture and food security. Founded in 2022 by Professor Jae-Yean Kim, the company utilizes advanced technologies such as prime editing to develop genetically enhanced crops, including functional tomatoes and cannabis with improved traits. Their core capabilities include proprietary gene-tagging, site-specific mutagenesis, and highly efficient transformation systems. The company operates as a research-intensive entity that provides specialized B2B services, including gene editing and research material development, to global researchers and agricultural enterprises.
By leveraging deep expertise in plant biology—specifically in areas like plasmodesmata and genetic regulation—Nulla Bio aims to create sustainable agricultural solutions, such as crops with increased nutritional value or removed harmful substances. Their technological advancements have been documented in leading scientific journals and secured through multiple international patents. Through these services and R&D activities, the company supports the wider plant research community, helping partners and clients save time and resources in developing climate-resilient and functional crop varieties.